Epigenetic regulation of MHC-II and CIITA genes
- PMID: 16870508
- DOI: 10.1016/j.it.2006.07.007
Epigenetic regulation of MHC-II and CIITA genes
Abstract
This review describes recent advances in understanding how epigenetic events control MHC-class-II-family (MHC-II) gene expression. To address this issue, two phases of gene transcription have to be considered. First, the control of MHC-II by chromatin-modifying events such as histone acetylation, methylation, deacetylation, ubiquitination and the interplay between these different epigenetic events will be examined. The interactions of chromatin-modifying enzymes with class II transactivator (CIITA) and relevant DNA-binding proteins for activating and silencing MHC-II gene transcription will be reviewed. Second, the transcriptional control of the promoter of CIITA, the master regulator of MHC-II, by DNA methylation and chromatin modification will be discussed, and the novel role of noncoding RNA will be explored. Finally, the relevance of these findings to infection, transplantation and cancer will be reviewed.
Similar articles
-
Epigenetic control of MHC-II: interplay between CIITA and histone-modifying enzymes.Curr Opin Immunol. 2005 Feb;17(1):58-64. doi: 10.1016/j.coi.2004.11.008. Curr Opin Immunol. 2005. PMID: 15653312 Review.
-
Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter.Eur J Immunol. 2009 Mar;39(3):858-68. doi: 10.1002/eji.200838674. Eur J Immunol. 2009. PMID: 19224634
-
Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes.Eur J Immunol. 2004 Jun;34(6):1513-25. doi: 10.1002/eji.200424964. Eur J Immunol. 2004. PMID: 15162420 Review.
-
Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.Invest Ophthalmol Vis Sci. 2004 Sep;45(9):3185-95. doi: 10.1167/iovs.04-0111. Invest Ophthalmol Vis Sci. 2004. PMID: 15326139
-
A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites.Eur J Immunol. 2004 Feb;34(2):471-80. doi: 10.1002/eji.200324195. Eur J Immunol. 2004. PMID: 14768052
Cited by
-
Role of Sug1, a 19S proteasome ATPase, in the transcription of MHC I and the atypical MHC II molecules, HLA-DM and HLA-DO.Immunol Lett. 2012 Sep;147(1-2):67-74. doi: 10.1016/j.imlet.2012.06.005. Epub 2012 Jul 4. Immunol Lett. 2012. PMID: 22771340 Free PMC article.
-
An N- and C-terminal truncated isoform of zinc finger X-linked duplicated C protein represses MHC class II transcription.Mol Cell Biochem. 2010 Apr;337(1-2):1-7. doi: 10.1007/s11010-009-0280-5. Epub 2009 Sep 24. Mol Cell Biochem. 2010. PMID: 19777325 Free PMC article.
-
Chromatin structure undergoes global and local reorganization during murine dendritic cell development and activation.Proc Natl Acad Sci U S A. 2022 Aug 23;119(34):e2207009119. doi: 10.1073/pnas.2207009119. Epub 2022 Aug 15. Proc Natl Acad Sci U S A. 2022. PMID: 35969760 Free PMC article.
-
Contrasting effects of IFNα on MHC class II expression in professional vs. nonprofessional APCs: Role of CIITA type IV promoter.Results Immunol. 2012 Sep 27;2:174-83. doi: 10.1016/j.rinim.2012.09.001. eCollection 2012. Results Immunol. 2012. PMID: 24371581 Free PMC article.
-
Methylation of CIITA promoter IV causes loss of HLA-II inducibility by IFN-gamma in promyelocytic cells.Int Immunol. 2008 Nov;20(11):1457-66. doi: 10.1093/intimm/dxn103. Epub 2008 Oct 1. Int Immunol. 2008. PMID: 18829986 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials